<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2020-15-10-14</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-1595</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Минеральная плотность костной ткани и аппендикулярная мышечная масса у больных ревматоидным артритом</article-title><trans-title-group xml:lang="en"><trans-title>Bone mineral density and appendicular muscle mass in patients with rheumatoid arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Добровольская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dobrovolskaya</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, научный сотрудник лаборатории остеопороза</p><p>Москва </p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торопцова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Toroptsova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, заведующий лабораторией остеопороза</p><p>Москва </p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черкасова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Cherkasova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат биологических наук, заведующий лабораторией иммунологии и молекулярной биологии ревматических заболеваний</p><p>Москва</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самаркина</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Samarkina</surname><given-names>E. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Младший научный сотрудник лаборатории иммунологии и молекулярной биологии ревматических заболеваний</p><p>Москва </p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитинская</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitinskaya</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, старший научный сотрудник лаборатории остеопороза</p><p>Москва</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демин</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dyomin</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Младший научный сотрудник лаборатории остеопороза</p><p>Москва</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии имени В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>12</day><month>09</month><year>2020</year></pub-date><volume>0</volume><issue>15 (2020)</issue><issue-title>Ревматология в общей практике</issue-title><fpage>10</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Добровольская О.В., Торопцова Н.В., Черкасова М.В., Самаркина Е.Ю., Никитинская О.А., Демин Н.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Добровольская О.В., Торопцова Н.В., Черкасова М.В., Самаркина Е.Ю., Никитинская О.А., Демин Н.В.</copyright-holder><copyright-holder xml:lang="en">Dobrovolskaya O.V., Toroptsova N.V., Cherkasova M.V., Samarkina E.Y., Nikitinskaya O.A., Dyomin N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/1595">https://www.med-alphabet.com/jour/article/view/1595</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: изучить состояние минеральной плотности костей (МПК) и аппендикулярной мышечной массы (АММ), их взаимосвязь и связь с потреблением кальция и уровнем витамина D у женщин с ревматоидным артритом (РА).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Включено 43 женщины (средний возраст 57,5 ± 7,0 года) с достоверным РА. Проведены анкетирование, двуэнергетическая рентгеновская абсорбциометрия поясничного отдела позвоночника, бедра и всего тела, оценены потребление кальция с пищей и уровень витамина D в крови.</p></sec><sec><title>Результаты</title><p>Результаты. Сниженная МПК выявлена у 76,8%, в том числе остеопороз (ОП) – у 23,3%, а остеопения – у 53,5% человек. Низкая АММ встречалась у 11,6%, а сниженный аппендикулярный мышечный индекс (АМИ) – у 18,6% обследованных лиц. Женщины с низкой МПК имели значимо более низкие показатели АММ и АМИ, чем пациентки с нормальной МПК. Среднее потребление кальция составило 737 мг в сутки, при этом оно было меньше у пациентов с ОП по сравнению с лицами с нормальной МПК (р = 0,038). Среди всех женщин 56% лиц нуждались в дополнительном назначении препаратов кальция. Уровень витамина D в сыворотке крови составил 20,8 нг/мл, при этом частота недостаточности – 48,8%, а дефицита – 41,9% без значимых различий между лицами с ОП, остеопенией и нормальной МПК.</p></sec><sec><title>Заключение</title><p>Заключение. У женщин с РА сниженная МПК встречалась в 76,8%, сниженная АММ – в 11,6%, а низкий АМИ – в 18,6% случаев. Лица с низкой МПК имели более низкие показатели АММ и АМИ, чем пациенты с нормальной МПК. Потребление кальция было значимо меньше у женщин с ОП по сравнению с лицами с нормальной МПК.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To study the bone mineral density (BMD) and appendicular muscle mass (AMM), their interrelation and relationship with calcium intake and vitamin D level in women with rheumatoid arthritis (RA).</p></sec><sec><title>Material and methods</title><p>Material and methods. 43 women (mean age 57.5 ± 7.0 years) with confirmed RA were included. All patients were interviewed using a special questionnaire. Dual-energy X-ray absorptiometry (DXA) of lumbar spine, hip and total body was performed, and dietary calcium intake and vitamin D blood serum levels were assessed.</p></sec><sec><title>Results</title><p>Results. Reduced BMD was detected in 76.8% of patients, including osteoporosis (OP) – in 23.3%, and osteopenia – in 53.5% of women. Low AMM was found in 11.6%, and reduced appendicular muscle index (AMI) was found in 18.6% of the examined patients. Women with low BMD had significantly lower AMM and AMI scores than patients with normal BMD. The average calcium intake was 737 mg per day, while it was lower in patients with OP compared to those with normal BMD (p = 0.038). Among all women, 56% of individuals needed additional calcium supplementation. The average level of vitamin D in the blood serum was 20.8 ng/ml, with the incidence of insufficiency – 48.8%, and deficiency – 41.9% without significant differences between individuals with OP, osteopenia and normal BMD.</p></sec><sec><title>Conclusion</title><p>Conclusion. In women with RA, reduced BMD was found in 76.8%, reduced AMM – in 11.6%, and low AMI – in 18.6% of cases. Patients with low BMD had lower AMM and AMI than women with normal BMD. Calcium intake was significantly lower in patients with OP compared to those with normal BMD.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ревматоидный артрит</kwd><kwd>остеопороз</kwd><kwd>минеральная плотность кости</kwd><kwd>мышечная масса</kwd><kwd>потребление кальция</kwd><kwd>витамин D</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rheumatoid arthritis</kwd><kwd>osteoporosis</kwd><kwd>bone mineral density</kwd><kwd>muscle mass</kwd><kwd>calcium intake</kwd><kwd>vitamin D</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Popescu C, Bojincă V, Opriş D, Ionescu R. Whole body bone tissue and cardiovascular risk in rheumatoid arthritis. J Osteoporos. 2014; 2014: 465987. DOI: 10.1155/2014/465987.</mixed-citation><mixed-citation xml:lang="en">Popescu C, Bojincă V, Opriş D, Ionescu R. Whole body bone tissue and cardiovascular risk in rheumatoid arthritis. J Osteoporos. 2014; 2014: 465987. DOI: 10.1155/2014/465987.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lemmey AB, Wilkinson TJ, Clayton RJ et al. Tight control of disease activity fails to improve body composition or physical function in rheumatoid arthritis patients. Rheumatology (Oxford). 2016; 55(10): 1736–45. DOI: 10.1093/rheumatology/kew243.</mixed-citation><mixed-citation xml:lang="en">Lemmey AB, Wilkinson TJ, Clayton RJ et al. Tight control of disease activity fails to improve body composition or physical function in rheumatoid arthritis patients. Rheumatology (Oxford). 2016; 55(10): 1736–45. DOI: 10.1093/rheumatology/kew243.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman Y P, et al. Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Ann Rheum Dis 2007; 66: 1508–1512. DOI: 10.1136/ard.2007.070839.</mixed-citation><mixed-citation xml:lang="en">Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman Y P, et al. Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Ann Rheum Dis 2007; 66: 1508–1512. DOI: 10.1136/ard.2007.070839.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Таскина ЕА, Алексеева ЛИ, Дыдыкина ИС и др. Факторы риска развития остеопоропоза у больных ревматоидным артритом (предварительные результаты по материалам многоцентровой программы «Остеопороз при ревматоидном артрите: диагностика, факторы риска, переломы, лечение»). Научно-практическая ревматология. 2014; 52 (4): 393–7. DOI: 10.14412/1995–4484–2014–393–397.</mixed-citation><mixed-citation xml:lang="en">Таскина ЕА, Алексеева ЛИ, Дыдыкина ИС и др. Факторы риска развития остеопоропоза у больных ревматоидным артритом (предварительные результаты по материалам многоцентровой программы «Остеопороз при ревматоидном артрите: диагностика, факторы риска, переломы, лечение»). Научно-практическая ревматология. 2014; 52 (4): 393–7. DOI: 10.14412/1995–4484–2014–393–397.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">С.Е. Мясоедова, О.А. Рубцова, Е.Е. Мясоедова. Композиционный состав тела и минеральная плотность кости у женщин при ревматоидном артрите. Клиницист, 2016; 10 (3): 41–45. DOI: 10.17650/1818–8338–2016–10–3–41–45.</mixed-citation><mixed-citation xml:lang="en">С.Е. Мясоедова, О.А. Рубцова, Е.Е. Мясоедова. Композиционный состав тела и минеральная плотность кости у женщин при ревматоидном артрите. Клиницист, 2016; 10 (3): 41–45. DOI: 10.17650/1818–8338–2016–10–3–41–45.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ngeuleu A, Allali F, Medrare L et al. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatology International, 2017; 37 (6): 1015–1020. DOI: 10.1007/s00296–017–3665-x.</mixed-citation><mixed-citation xml:lang="en">Ngeuleu A, Allali F, Medrare L et al. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatology International, 2017; 37 (6): 1015–1020. DOI: 10.1007/s00296–017–3665-x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mochizuki T, Yano K, Ikari K, Okazaki K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatrics &amp; Gerontology International, 2019; 19 (9): 907–912. DOI: 10.1111/ggi.13747.</mixed-citation><mixed-citation xml:lang="en">Mochizuki T, Yano K, Ikari K, Okazaki K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatrics &amp; Gerontology International, 2019; 19 (9): 907–912. DOI: 10.1111/ggi.13747.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39 (4): 412–23. DOI: 10.1093/ageing/afq034.</mixed-citation><mixed-citation xml:lang="en">Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39 (4): 412–23. DOI: 10.1093/ageing/afq034.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz-Jentoft AJ, Bahat G, Bauer JM et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48 (1): 16–31. DOI: 10.1093/ageing/afy169.</mixed-citation><mixed-citation xml:lang="en">Cruz-Jentoft AJ, Bahat G, Bauer JM et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48 (1): 16–31. DOI: 10.1093/ageing/afy169.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JH, Sung YK, Choi CB et al. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016; 17: 98. DOI: 10.1186/s12891–016–0952–8.</mixed-citation><mixed-citation xml:lang="en">Lee JH, Sung YK, Choi CB et al. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016; 17: 98. DOI: 10.1186/s12891–016–0952–8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Haugeberg G, Uhlig T, Falch JA et al. Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis. Arthritis and Rheumatism. 2002; 61 (12): 1085–1089. DOI: 10.1136/ard.61.12.1085.</mixed-citation><mixed-citation xml:lang="en">Haugeberg G, Uhlig T, Falch JA et al. Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis. Arthritis and Rheumatism. 2002; 61 (12): 1085–1089. DOI: 10.1136/ard.61.12.1085.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tawaratsumida H, Setoguchi T, Arishima Y et al. BMC Res Notes. Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs. 2017; 10: 765. DOI: 10.1186/s13104–017–3086–7.</mixed-citation><mixed-citation xml:lang="en">Tawaratsumida H, Setoguchi T, Arishima Y et al. BMC Res Notes. Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs. 2017; 10: 765. DOI: 10.1186/s13104–017–3086–7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sarkis KS, Salvador MB, Pinheiro MM et al. Association between osteoporosis and rheumatoid arthritis in women: a cross-sectional study. Sao Paulo Med J. 2009 Jul; 127 (4): 216–22. DOI: 10.1590/s1516–31802009000400007.</mixed-citation><mixed-citation xml:lang="en">Sarkis KS, Salvador MB, Pinheiro MM et al. Association between osteoporosis and rheumatoid arthritis in women: a cross-sectional study. Sao Paulo Med J. 2009 Jul; 127 (4): 216–22. DOI: 10.1590/s1516–31802009000400007.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Barone M, Viggiani MT, Anelli MG et al. Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors. Journal of Clinical Medicine, 2018; 7 (12): 504. DOI: 10.3390/jcm7120504.</mixed-citation><mixed-citation xml:lang="en">Barone M, Viggiani MT, Anelli MG et al. Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors. Journal of Clinical Medicine, 2018; 7 (12): 504. DOI: 10.3390/jcm7120504.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Vlietstra L, Stebbings S, Meredith-Jones K et al. Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity. PLoS ONE, 2019; 14 (6): e0217462. DOI: 0.1371/journal.pone.0217462.</mixed-citation><mixed-citation xml:lang="en">Vlietstra L, Stebbings S, Meredith-Jones K et al. Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity. PLoS ONE, 2019; 14 (6): e0217462. DOI: 0.1371/journal.pone.0217462.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mochizuki T, Yano K, Ikari K, Okazaki K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatrics &amp; Gerontology International, 2019; 19 (9): 907–912. DOI: 10.1111/ggi.13747.</mixed-citation><mixed-citation xml:lang="en">Mochizuki T, Yano K, Ikari K, Okazaki K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatrics &amp; Gerontology International, 2019; 19 (9): 907–912. DOI: 10.1111/ggi.13747.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Torii M, Hashimoto M, Hanai A et al. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatrics &amp; Gerontology International, 2019; 19 (9): 907–912. DOI: 10.1111/ggi.13747.</mixed-citation><mixed-citation xml:lang="en">Torii M, Hashimoto M, Hanai A et al. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatrics &amp; Gerontology International, 2019; 19 (9): 907–912. DOI: 10.1111/ggi.13747.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kinjo M, Setoguchi S, Solomon DH. Bone mineral density in older adult patients with rheumatoid arthritis: an analysis of NHANES III. J Rheumatol. 2007; 34 (10): 1971–5.</mixed-citation><mixed-citation xml:lang="en">Kinjo M, Setoguchi S, Solomon DH. Bone mineral density in older adult patients with rheumatoid arthritis: an analysis of NHANES III. J Rheumatol. 2007; 34 (10): 1971–5.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng ZH, Gao CC, Wu ZZ et al. High prevalence of hypovitaminosis D of patients with autoimmune rheumatic diseases in China. Am J Clin Exp Immunol. 2016 Jun 1; 5 (3): 48–54.</mixed-citation><mixed-citation xml:lang="en">Zheng ZH, Gao CC, Wu ZZ et al. High prevalence of hypovitaminosis D of patients with autoimmune rheumatic diseases in China. Am J Clin Exp Immunol. 2016 Jun 1; 5 (3): 48–54.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
